Use this framework to facilitate complex decisions for treatment anddisease managementMedicine is both an art and a science. One hundred years ago, physiciansplaced more emphasis on the art than on the science, as documented studiessupporting the scientific basis for therapeutic decisions were few and farbetween. Since the 1990s, a plethora of information has become availableon studies, research, and scientific investigation on the treatment of disease,outcomes, and management of entire patient populations.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
June 22nd 2023"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.
2 Clarke Drive
Cranbury, NJ 08512